Showing results (41-50 of 112) with videos related to
Sort By:
Pageof 12
Pharmacology & Therapeutics|December 28, 2020
Role of inflammatory chemokines in hypertensionTomasz P Mikolajczyk, Piotr Szczepaniak, Francesca Vidler, et al.Molecular Pharmacology|June 20, 2003
Anti-inflammatory activity of 15-deoxy-delta12,14-PGJ2 and 2-cyclopenten-1-one: role of the heat shock responseAngela Ianaro, Armando Ialenti, Pasquale Maffia, et al.FEBS Letters|October 11, 2003
2-Cyclopenten-1-one and prostaglandin J2 reduce restenosis after balloon angioplasty in rats: role of NF-kappaBAngela Ianaro, Pasquale Maffia, Salvatore Cuzzocrea, et al.Clinical Hypertension|March 9, 2026
24-Hour ambulatory blood pressure and C-reactive protein: a systematic review and meta-analysisJoanna Sulicka-Grodzicka, Karolina Piotrowicz, Marcin Cwynar, et al.The Journal of Biological Chemistry|April 30, 2015
Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory PeptidePatricia E Collins, Gianluca Grassia, Amy Colleran, et al.Circulation|July 26, 2006
Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injuryPasquale Maffia, Gianluca Grassia, Paola Di Meglio, et al.Journal of Medicinal Chemistry|October 28, 2005
Discovery and biological evaluation of the novel naturally occurring diterpene pepluanone as antiinflammatory agentGabriella Corea, Ernesto Fattorusso, Virginia Lanzotti, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2023
Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocityAntonio Iaconelli, Joe Cuthbert, Syed Kazmi, et al.British Journal of Pharmacology|October 1, 2025
Resolution of inflammation in pulmonary arterial hypertension, the influence of sex-An IUPHAR immunopharmacology committee reviewChloe Landy, Miles J De Blasio, Owen L Woodman, et al.British Journal of Pharmacology|November 20, 2016
Effect of sphingosine kinase modulators on interleukin-1β release, sphingosine 1-phosphate receptor 1 expression and experimental autoimmune encephalomyelitisMark Barbour, Melissa McNaughton, Stephanie D Boomkamp, et al.Pageof 12